Home/Filings/4/0001654954-22-000250
4//SEC Filing

MICHEL KIRK WHEELER 4

Accession 0001654954-22-000250

CIK 0001304161other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 8:14 PM ET

Size

9.1 KB

Accession

0001654954-22-000250

Insider Transaction Report

Form 4
Period: 2022-01-04
MICHEL KIRK WHEELER
DirectorChairman
Transactions
  • Exercise/Conversion

    Stock Option

    2022-01-0420,0000 total
    Exercise: $0.91Exp: 2022-01-10Common Stock (20,000 underlying)
  • Exercise/Conversion

    Common Stock

    2022-01-04$0.91/sh+20,000$18,20052,706 total
  • Tax Payment

    Common Stock

    2022-01-04$1.03/sh17,670$18,20035,036 total
Holdings
  • Common Stock

    (indirect: By Kema Advisors, Inc.)
    340,706
Footnotes (4)
  • [F1]Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
  • [F2]Shares reported in this column have been updated to properly reflect the shares held by the reporting person following the transactions on January 4, 2021.
  • [F3]The reporting person is the sole shareholder of this entity.
  • [F4]The option vested in two equal installments on July 10, 2017 and July 10, 2018.

Issuer

Pharma-Bio Serv, Inc.

CIK 0001304161

Entity typeother

Related Parties

1
  • filerCIK 0001351095

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:14 PM ET
Size
9.1 KB